Allecra Therapeutics is a clinical stage biopharmaceutical company, develops pharmaceuticals to treat gram-negative multidrug-resistant bacterial infections. Its mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms thereby saving lives of patients whose infections may otherwise may be inadequately treated.